03.01.2024 - –Mitapivat Demonstrated a Statistically Significant Increase in Hemoglobin Response Rate Compared to Placebo – – Statistical Significance Also Achieved for Key Secondary Endpoints of Change From Baseline in Both FACIT-Fatigue Score and Hemoglobin . Seite 1
The phase 3 STAND study contrasts from the phase 2 SUSTAIN study results, highlighting the absence of superiority of crizanlizumab over placebo on key efficacy endpoints.
The Institute for Palestine Studies (IPS), in collaboration with the Global Health Institute (GHI) at the American University of Beirut (AUB) and the Arab Center for Research and Policy Studies (ACRPS), is honored to invite you to our upcoming event "Wounds of War: The Gaza Experience Through the Eyes of Dr. Ghassan Abu Sitta." The event will be livestreamed via IPS's English
The lecture will provide insight into Dr. Ghassan Abu-Sittah’s field experience during the ongoing genocidal war on Gaza as a firsthand witness to Israel’s systematic destruction of the health sector. The atrocities represent an attempt to ethnically cleanse Gaza and render it uninhabitable. Abu-Sitta will talk about the collective responsibility to prevent this from